当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析

普洛药业

(000739)

  

流通市值:207.05亿  总市值:207.13亿
流通股本:11.58亿   总股本:11.58亿

普洛药业(000739)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年年度实现净利润8.91亿元,每股收益0.77元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年年度最新股东权益634634.92万元,未分配利润511397.17万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年年度最新总资产1231826.33万元,负债597191.41万元。

利润表
报告期2025-12-312025-09-302025-06-302025-03-31
营业总收入9,783,600,915.277,763,882,133.275,444,486,087.312,730,189,121.97
营业总成本8,789,064,728.766,996,741,278.284,838,162,638.12,490,659,565.28
其他经营收益
营业利润1,070,863,560.26842,655,816.16660,249,384.93298,437,200.12
利润总额1,066,198,868.98839,139,546.78658,587,798.37297,471,282.94
净利润890,681,701.93700,189,009.91563,071,412.09248,576,261.58
每股收益
其他综合收益300,145.47937,413.11318,525.6391,753.66
综合收益总额890,981,847.4701,126,423.02563,389,937.72248,668,015.24
资产负债表
报告期2025-12-312025-09-302025-06-302025-03-31
流动资产:
流动资产合计7,878,965,938.37,585,032,315.138,011,650,969.638,228,646,015.77
非流动资产:
非流动资产合计4,439,297,353.694,516,930,484.214,471,960,429.194,479,894,940.95
资产总计12,318,263,291.9912,101,962,799.3412,483,611,398.8212,708,540,956.72
流动负债:
流动负债合计5,365,151,090.125,316,853,533.245,382,021,923.245,466,974,634.36
非流动负债:
非流动负债合计606,763,046.04290,916,547.6345,083,373.18243,015,127.4
负债合计5,971,914,136.165,607,770,080.845,727,105,296.425,709,989,761.76
所有者权益(或股东权益):
归属于母公司股东权益合计6,338,427,056.56,486,351,400.776,748,563,568.946,990,603,683.93
股东权益合计6,346,349,155.836,494,192,718.56,756,506,102.46,998,551,194.96
负债和股东权益合计12,318,263,291.9912,101,962,799.3412,483,611,398.8212,708,540,956.72
现金流量表
报告期2025-12-312025-09-302025-06-302025-03-31
经营活动产生的现金流量:
经营活动现金流入小计8,544,405,781.596,293,882,351.314,128,407,073.222,227,671,600.39
经营活动现金流出小计7,324,204,500.845,519,858,244.643,721,226,512.92,242,665,069.55
经营活动产生的现金流量净额1,220,201,280.75774,024,106.67407,180,560.32-14,993,469.16
投资活动产生的现金流量:
投资活动现金流入小计1,312,869,961.15986,330,907.92543,989,471.66271,293,102.69
投资活动现金流出小计1,685,187,950.81,224,656,435.27672,733,223.93362,663,790.84
投资活动产生的现金流量净额-372,317,989.65-238,325,527.35-128,743,752.27-91,370,688.15
筹资活动产生的现金流量:
筹资活动现金流入小计2,134,900,0001,620,900,0001,062,900,000296,900,000
筹资活动现金流出小计2,777,986,444.152,190,685,623.071,283,559,126.65328,296,306.27
筹资活动产生的现金流量净额-643,086,444.15-569,785,623.07-220,659,126.65-31,396,306.27
汇率变动对现金及现金等价物的影响-9,951,342.783,355,523.377,432,261.763,246,242.93
现金及现金等价物净增加额194,845,504.17-30,731,520.3865,209,943.16-134,514,220.65
期末现金及现金等价物余额2,924,290,064.232,698,713,039.682,794,654,503.222,594,930,339.41
补充资料:
现金及现金等价物的净增加额194,845,504.17-65,209,943.16-
最新报告期:2026-04-01
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西部证券李梦园0.951.151.372026-04-01
中信证券陈竹,王凯旋0.911.061.272026-03-30
中信建投刘若飞,王云鹏,袁清慧,贺菊颖0.891.081.322026-03-29
中泰证券祝嘉琦0.891.061.272026-03-27
招商证券侯彪,梁广楷,许菲菲0.911.091.332026-03-26
TOP↑